Roche has introduced a new PCR test for vaginitis that detects bacteria linked to bacterial vaginosis and yeast associated with candida vaginitis. This test provides faster and more accurate diagnosis for the millions of women affected by vaginitis annually, using only a single vaginal swab. Traditional methods like microscopy and pH testing can yield inaccurate results, leading to delays in treatment. The new cobas BV/CV assay offers precise results, enabling healthcare professionals to deliver targeted therapies quickly. This advancement is crucial as vaginitis symptoms are common and can be uncomfortable, potentially indicating more serious issues like STIs. A new PCR test has been developed to aid in diagnosing infectious causes of vaginitis by detecting bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis. The test is expected to improve diagnostic accuracy for the millions of women affected by vaginitis annually, providing more specific results. It offers faster diagnosis by using a single vaginal swab for broader sexual health testing, eliminating the need for an additional sample.

Read more at “GlobeNewswire”

A new PCR test has been developed to aid in diagnosing infectious causes of vaginitis by detecting bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis. This test is expected to improve diagnostic accuracy for the millions of women affected by vaginitis annually. By using a single vaginal swab for testing, the new PCR test offers a faster diagnosis and eliminates the need for additional samples.: Roche launches new PCR test to help improve diagnostic